Anaplastic Multiple Myeloma: An Aggressive Variant With a Poor Response to Novel Therapies
- 1 September 2016
- journal article
- case report
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 16 (9) , e129-e131
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Genomic aberrations in anaplastic multiple myeloma: High frequency of 1q21(CKS1B) amplificationsLeukemia Research, 2013
- Anaplastic myeloma: a morphologic diagnostic dilemmaIndian Journal of Hematology and Blood Transfusion, 2008
- CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanismsBlood, 2007
- Amplification and overexpression of CKS1B at chromosome band 1q21 is associated with reduced levels of p27 Kip1 and an aggressive clinical course in multiple myelomaHematology, 2005
- Multiple chromosomal abnormalities in fulminant anaplastic myelomaClinical and Laboratory Haematology, 1999
- Anaplastic MyelomaLeukemia & Lymphoma, 1995
- Aggressive Phase Multiple Myeloma: A Terminal Anaplastic Transformation Resembling High-Grade LymphomaCancer Investigation, 1990
- Anaplastic myeloma in systemic lupus erythematosus.Annals of the Rheumatic Diseases, 1984
- Anaplastic myeloma with massive extramedullar involvement: Report of two casesCancer, 1983
- Aggressive Plasma Cell MyelomaArchives of internal medicine (1960), 1981